Biobanking of Specimens from COVID-19 Patients: An Economic Perspective from a Clinical Biobank.

Niedermair, Tanja; Bhatt, Meet; Wallner, Stefan; Babel, Maximilian; Burkhardt, Ralph; Brochhausen, Christoph

Niedermair, Tanja; Bhatt, Meet; Wallner, Stefan; Babel, Maximilian; Burkhardt, Ralph; Brochhausen, Christoph.

Niedermair T; Institute of Pathology, University Regensburg, Regensburg, Germany.
Bhatt M; Central Biobank Regensburg, University and University Hospital Regensburg, Regensburg, Germany.
Wallner S; Biobank Cote d'Azur, Centre Hospitalier Universitaire de Nice, University Cote D'Azur, Nice, France.
Babel M; Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany.
Burkhardt R; Institute of Pathology, University Regensburg, Regensburg, Germany.
Brochhausen C; Central Biobank Regensburg, University and University Hospital Regensburg, Regensburg, Germany.

Biopreserv Biobank ; 19(5): 453-456, 2021 10.

Article in English | MEDLINE | ID: covidwho-1244870

Subject(s)

Biomedical Research; COVID-19; Biological Specimen Banks; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Biomedical Research / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Biopreserv Biobank Year: 2021 Document Type: Article Affiliation country: Bio.2020.0168

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google